296 related articles for article (PubMed ID: 26713055)
1. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
Ah YM; Lee JY; Choi YJ; Kim B; Choi KH; Kong J; Oh JM; Shin WG; Lee HY
J Korean Med Sci; 2015 Dec; 30(12):1800-6. PubMed ID: 26713055
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.
Tu K; Anderson LN; Butt DA; Quan H; Hemmelgarn BR; Campbell NR; McAlister FA;
Can J Cardiol; 2014 Jun; 30(6):647-52. PubMed ID: 24882536
[TBL] [Abstract][Full Text] [Related]
3. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.
Bourgault C; Sénécal M; Brisson M; Marentette MA; Grégoire JP
J Hum Hypertens; 2005 Aug; 19(8):607-13. PubMed ID: 15920457
[TBL] [Abstract][Full Text] [Related]
4. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
[TBL] [Abstract][Full Text] [Related]
5. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.
Schulz M; Krueger K; Schuessel K; Friedland K; Laufs U; Mueller WE; Ude M
Int J Cardiol; 2016 Oct; 220():668-76. PubMed ID: 27393848
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
7. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
[TBL] [Abstract][Full Text] [Related]
8. [Persistence and adherence: Comparison between the five classes diuretics, beta-blocker, calcium channel blockers, ACE-inhibitors and angiotensin receptor blockers as the first line in antihypertensive therapy].
Rossol-Haseroth K; Eckes L; Schroeder A
MMW Fortschr Med; 2011 Mar; 153 Suppl 1():21-5. PubMed ID: 21591327
[No Abstract] [Full Text] [Related]
9. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.
Patel BV; Remigio-Baker RA; Mehta D; Thiebaud P; Frech-Tamas F; Preblick R
J Clin Hypertens (Greenwich); 2007 Sep; 9(9):692-700. PubMed ID: 17786070
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
11. Persistence with antihypertensives in uncomplicated treatment-naïve very elderly patients: a nationwide population-based study.
Choi KH; Yu YM; Ah YM; Chang MJ; Lee JY
BMC Cardiovasc Disord; 2017 Aug; 17(1):232. PubMed ID: 28836946
[TBL] [Abstract][Full Text] [Related]
12. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
[TBL] [Abstract][Full Text] [Related]
13. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study.
Erkens JA; Panneman MM; Klungel OH; van den Boom G; Prescott MF; Herings RM
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):795-803. PubMed ID: 16178043
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis: impact of drug class on adherence to antihypertensives.
Kronish IM; Woodward M; Sergie Z; Ogedegbe G; Falzon L; Mann DM
Circulation; 2011 Apr; 123(15):1611-21. PubMed ID: 21464050
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive Drugs and Diabetic Retinopathy in Patients with Type 2 Diabetes.
Lin JC; Lai MS
Ophthalmologica; 2016; 235(2):87-96. PubMed ID: 26695432
[TBL] [Abstract][Full Text] [Related]
16. Treatment of uncomplicated hypertension is associated with a reduction in cardiovascular mortality: a Korean national cohort study.
Lee CJ; Hwang J; Oh J; Lee SH; Kang SM; Choi D; Kim HC; Park S
J Hypertens; 2017 May; 35 Suppl 1():S41-S49. PubMed ID: 28350620
[TBL] [Abstract][Full Text] [Related]
17. Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients.
Cho MA; Jeong SY; Sohn I; Kim MS; Kang JH; Paik ES; Lee YY; Choi CH
Cancer Res Treat; 2020 Apr; 52(2):645-654. PubMed ID: 32019281
[TBL] [Abstract][Full Text] [Related]
18. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
20. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
Simonyi G; Ferenci T; Finta E; Igaz I; Balogh S; Gasparics R; Medvegy M
Orv Hetil; 2019 Mar; 160(9):343-348. PubMed ID: 30798621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
